SCHEMBL7799255

SCHEMBL7799255

O=C(NC(CSSCC(NC(=O)c1ccc(Cl)cc1)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
KMT2A Q03164 1/20 0.49
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MAPT P10636 2/20 0.49
CYP1A2 P05177 1/20 0.49
GAA P10253 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
GFER P55789 1/20 0.49
CTSL P07711 1/20 0.48
CTSB P07858 1/20 0.48
CNR1 P21554 2/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
F11 P03951 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CNR2 P34972 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793390 0.91 KMT2A (0.57) L3MBTL1KMT2ANPC1RAB9ACTSL
SCHEMBL7798889 0.88 NPC1 (0.64) L3MBTL1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL7798884 0.85 ALDH1A1 (0.58) L3MBTL1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL7793435 0.80 CA12 (0.52) KMT2ASMN1; SMN2CYP2D6CYP2C19
SCHEMBL2246542 0.80 TDP1 (0.56) L3MBTL1CNR1TDP1
SCHEMBL28551980 0.79 RAB9A (0.74) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7799262 0.78 POLB (0.52) KMT2ACYP2D6CYP2C19
SCHEMBL20777179 0.77 L3MBTL1 (0.67) L3MBTL1KMT2ACTSLCTSBCNR1
SCHEMBL20777238 0.77 L3MBTL1 (0.67) L3MBTL1KMT2ACTSLCTSBCNR1
SCHEMBL24119968 0.76 NPC1 (0.60) L3MBTL1KMT2ANPC1RAB9ACTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed